Re: Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.
Objective To investigate whether supplementing older adults with monthly doses of vitamin D alters the incidence of major cardiovascular events.
Design Randomised, double blind, placebo controlled trial of monthly vitamin D (the D-Health Trial). Computer generated permuted block randomisation was used to allocate treatments.
Setting Australia from 2014 to 2020.
Participants 21 315 participants aged 60-84 years at enrolment. Exclusion criteria were self-reported hypercalcaemia, hyperparathyroidism, kidney stones, osteomalacia, sarcoidosis, taking >500 IU/day supplemental vitamin D, or unable to give consent because of language or cognitive impairment.
Intervention 60 000 IU/month vitamin D3 (n=10 662) or placebo (n=10 653) taken orally for up to five years. 16 882 participants completed the intervention period: placebo 8270 (77.6%); vitamin D 8552 (80.2%).
Main outcome measures The main outcome for this analysis was the occurrence of a major cardiovascular event, inclu
This algorithm looks promising and would alert clinicians to often-missed patients with high fracture risk who need to be investigated for osteoporosis, an observer says, but it needs further validation.
Greater efforts are needed to prevent hip fractures and improve the treatment gap and post-fracture care, especially in men and the oldest old, say researchers.